1161. A Mid-Turbinate Swab Appears Comparable to Nasopharyngeal Swabs for Quantitative Detection of RSV in Infants
Session: Poster Abstract Session: Diagnostics: Viral
Friday, October 6, 2017
Room: Poster Hall CD
Posters
  • Blaschke IDWeek 2017 88x43@100%-printready.pdf (327.9 kB)
  • Background: Respiratory Syncytial Virus (RSV) is the most common cause of bronchiolitis and pneumonia in infants and children. Diagnosis of RSV can be made by molecular detection of the virus in a swab of respiratory secretions. Nasopharyngeal (NP) swabs are the most frequent swab type validated for the detection of RSV, and are often considered the “gold standard” for quantification studies. However, NP sampling is invasive and uncomfortable. We sought to determine whether a less invasive method, a mid-turbinate (MT) swab, was comparable to NP sampling for quantification of RSV in infants.

    Methods: We prospectively enrolled children < 24 months with a confirmed diagnosis of RSV and hospitalized at Primary Children’s Hospital (Salt Lake City, UT) during the 2015 – 2017 RSV seasons. Both an NP and MT swab were collected from each infant from different nostrils; subjects were randomized (1:1:1:1) as to the order of collection. After collection, parents were asked which collection method (NP vs. MT) they preferred. Viral loads were measured by real-time RT-qPCR. Correlation between the viral loads from the MT and NP swabs was examined. A mixed effect model was used to evaluate the mean (SD) viral loads.

    Results: 83 infants were enrolled and had swabs collected. Median age was 4 months [range 0-23]. 20 infants had swabs collected on multiple consecutive days. Median (Q1,Q3) duration of symptoms prior to enrollment was 5 days (4,7) Median (Q1,Q3) hospital stay length was 2 days (2,4). 1 infant was RSV negative according to the RT-qPCR assay. The mean (SD) viral loads were similar: 7.34 (1.26) and 7.09 (1.25) log10 copies/mL for 77 paired NP and MT swabs, respectively; see Figure 1 for median, range and quartiles. The correlation coefficient between the paired viral loads was high (0.82); see Figure 2 for Bland-Altman plot. Most parents (49/67 [73%]) who watched the swabbing preferred the MT to the NP swab.

    Conclusion: MT swabs perform as well as NP swabs for the quantification of RSV in infants. The difference in mean viral load is small compared to the standard deviation. The less invasive MT swabs are preferred by parents for sampling. MT swabs have the potential to replace the NP swab as the “gold standard” for quantitative respiratory viral sampling.

    Anne J. Blaschke, MD, PhD, FIDSA, FPIDS1, Matthew Mckevitt, PhD2, Krow Ampofo, MD, FIDSA, FPIDS.1, Tammi Lewis, BS3, Hao Chai, PhD2, Ying Guo, Ph.D.2, Julianna Dorsch, BS3, Erin Vanderhoof, BS3, Pricilla Rosen, BSc3, Volker Freimann, BS4, E. Kent Korgenski, MT, MS5, Seth Toback, M.D.2,6 and Jason Chien, MD2, (1)Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Utah School of Medicine, Salt Lake City, UT, (2)Gilead Sciences, Inc., Foster City, CA, (3)Clinical Trials Office, University of Utah School of Medicine, Salt Lake City, UT, (4)Critical Care, University of Utah School of Medicine, Salt Lake City, UT, (5)Department of Pediatrics, Pediatric Clinical Program, University of Utah School of Medicine and Intermountain Healthcare, Salt Lake City, UT, (6)Medical Affairs, PRA Health Sciences, Raleigh, NC

    Disclosures:

    A. J. Blaschke, Gilead Sciences, Inc: Investigator , Research support
    BioFire Diagnostics, LLC: Collaborator , I have intellectual property in BioFire Diagnostics through the University of Utah and Investigator , Licensing agreement or royalty and Research support

    M. Mckevitt, None

    K. Ampofo, None

    T. Lewis, None

    H. Chai, None

    Y. Guo, None

    J. Dorsch, None

    E. Vanderhoof, None

    P. Rosen, None

    V. Freimann, None

    E. K. Korgenski, None

    S. Toback, None

    J. Chien, None

    See more of: Diagnostics: Viral
    See more of: Poster Abstract Session

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.